Search alternatives:
significant 17 » significant _ (Expand Search), significant co (Expand Search), significant gap (Expand Search)
i decrease » _ decreased (Expand Search), _ decreases (Expand Search), nn decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search), mean decrease (Expand Search)
significant 17 » significant _ (Expand Search), significant co (Expand Search), significant gap (Expand Search)
i decrease » _ decreased (Expand Search), _ decreases (Expand Search), nn decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search), mean decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Metabolites with decreasing levels during the development.
Published 2025“…<p>Temporal profiles of polar metabolites and lipids with SCN levels significantly decreasing from E19 to P28. Rhythmicity was determined by eJTK; full or dashed lines depict the profiles that either did or did not pass the significance threshold (FDR-adjusted <i>P</i> < 0.05), respectively.…”
-
11
Inotodiol decreases clone formation in HCC cells.
Published 2025“…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …”
-
12
-
13
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
14
-
15
-
16
-
17
-
18
-
19
Nineteen SNPs with significant association (<i>P < </i>5 × 10<sup>−8</sup>) with risk on minJSW decrease in knee OA.
Published 2025“…<p>Nineteen SNPs with significant association (<i>P < </i>5 × 10<sup>−8</sup>) with risk on minJSW decrease in knee OA.…”
-
20